We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




World's First Fully Integrated Platform for Automated High Molecular Weight DNA Extraction

By LabMedica International staff writers
Posted on 23 May 2023

Long-read sequencing, a third-generation technology, throws light on certain "blind spots" that short-read sequencing methods cannot detect, such as complex structural variants. More...

However, isolating high-quality, high molecular weight (HMW) DNA, which is crucial for long-read sequencing, can be a formidable task. The majority of commercial extraction methods compromise the quality and length of the extracted DNA due to mechanical processes like centrifugation or vortexing, as well as alcohol precipitation. These methods tend to be labor-intensive. Now, a novel technology is revolutionizing nucleic acid extraction with a gentle, yet rapid chemistry-based method that selectively binds, gently clusters, and purifies intact DNA using controlled fluidics. This unique workflow is also non-volatile and does not require ethanol, ensuring convenient shipping and room-temperature storage.

One BioMed (Singapore) has launched the X8 HMW DNA Cartridge Kits for automated extraction of HMW DNA, specifically designed for long-read sequencing and genome assembly. The X8 HMW DNA Cartridge Kits, driven by the OneTouch Instrument, present the first globally automated platform for HMW DNA extraction from an array of samples including bacteria, plants, cell culture, tissue, and Peripheral Blood Mononuclear Cells (PBMCs). The kits contain all necessary reagents.

The Xceler8 Platform guarantees consistent and reproducible extraction of HMW DNA up to 2 Mb range from diverse sample types across different users. The purified HMW DNA is fit for a variety of downstream applications including long-read sequencing and de novo genome assembly. Thanks to the flexibility of random access, the Xceler8 Solution can run multiple protocols at the same time and efficiently process up to 8 samples within an hour. This fully integrated, plug-and-play automation system is perfect for labs seeking a highly flexible and consistent method of HMW DNA extraction from a wide variety of sample types.

"We are excited to launch the new X8 HMW DNA Cartridge Kit." said Dr.Mi Kyoung Park, Founder & CEO of One BioMed. "This Kit extends the workflow and performance advantages of the novel Xceler8 Technology, enabling scientists to efficiently extract HMW DNA from a variety of samples, for various downstream applications."

Related Links:
One BioMed 


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Respiratory Syncytial Virus Test
OSOM® RSV Test
New
Urine Drug Test
Instant-view® Phencyclidine Urine Drug Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Scanning electron microscopy images showing 3D micro-printed Limacon-shaped whispering-gallery-mode microcavities with different amounts of deformation (Photo courtesy of A. Ping Zhang/PolyU)

Tiny Microlaser Sensors with Supercharged Biosensing Ability to Enable Early Disease Diagnosis

Optical whispering-gallery-mode microlaser sensors function by trapping light within tiny microcavities. When target molecules bind to the cavity, they induce subtle changes in the laser’s frequency, allowing... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.